RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.

Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.

Add to Collection
2004 Sep Others Fist_Author_Year_PM

Full Author : ['Blonde, L', 'Joyal, S', 'Henry, D', 'Howlett, H']
Journal Title : International journal of clinical practice
Chapter : Section3
Journal Year : 2004
Cited by : Not Available

Oral anti-diabetic combinations that address insulin resistance and beta-cell dysfunction (e.g. metformin and glibenclamide) represent a rational therapeutic option for patients uncontrolled on monotherapy. A 52-week, open-label extension to a double-blin.....

Keywords : ["hyperglycaemia despite previous sulphonylurea monotherapy", "metforminglibenclamide combination tablet glucovance", "type diabetic patient", "openlabel treatment", "durable efficacy", "week"]